Research Article
Andrographolide Ameliorates Diabetic Cardiomyopathy in Mice by Blockage of Oxidative Damage and NF-κB-Mediated Inflammation
Figure 1
Andro treatment attenuates diabetes-induced myocardial dysfunction in vivo. (a) Representative M-mode echocardiograms (upper panel) and representative pulsed-wave Doppler echocardiograms of mitral inflow (lower panel). (b) Left ventricular ejection fraction (LVEF). (c) Fractional shortening (FS). (d) Early to late mitral flow (E/A). Control: normal mice; Andro: normal mice treated with Andro at a dose of 20 mg/kg/day orally by gavage; DM: diabetic mice. compared to control; compared to DM.
(a) |
(b) |
(c) |
(d) |